Market Place
Sourcing Support
All News #Library
Sciences
Tempus Announces Novel Pan-Cancer HRD-RNA Algorithm
18 Feb 2026 //
BUSINESSWIRE
Tempus Announces Collaboration with Median tech to Screening
12 Feb 2026 //
BUSINESSWIRE
Ambry Genetics Reaches 1M RNA Tests, Boosting Accuracy & Yield
02 Feb 2026 //
BUSINESSWIRE
Tempus Unveils Ai-Powered IPS Test For Enhanced Immunotherapy
27 Jan 2026 //
BUSINESSWIRE
Tempus Announces The Launch Of Paige Predict
21 Jan 2026 //
BUSINESSWIRE
Northwestern Medicine Selects Tempus To Expand Genomic Testing
12 Jan 2026 //
BUSINESSWIRE
Tempus To Present Eight Abstracts At 2026 ASCO Gi Cancers
08 Jan 2026 //
BUSINESSWIRE
Ambry Genetics 10-Year Study Shows Value of Exome Reanalysis
20 Oct 2025 //
BUSINESSWIRE
Tempus Chosen By ARPA-H For ADAPT Precision Cancer Program
09 Oct 2025 //
BUSINESSWIRE
Tempus Gets FDA 510(k) Clearance for xR IVD RNA NGS Device
22 Sep 2025 //
BUSINESSWIRE
Tempus Gets FDA 510(k) Clearance for Updated Pixel Device
11 Sep 2025 //
BUSINESSWIRE
Tempus Unveils Notetaker, AI Clinical Assistant for Psychiatry
05 May 2025 //
BUSINESSWIRE
Tempus Study Validates Benefits of xF+ Liquid Biopsy Assay
29 Apr 2025 //
BUSINESSWIRE
Tempus Introduces Loop, AI-Powered Target Discovery Platform
28 Apr 2025 //
BUSINESSWIRE
Tempus to Present 18 Abstracts at AACR Annual Meeting 2025
25 Apr 2025 //
BUSINESSWIRE
Tempus Molecular Profiling Now Available via Flatiron’s OncoEMR®
12 Nov 2024 //
BUSINESSWIRE
Tempus Presents Nine Abstracts at 2024 SITC Annual Meeting
08 Nov 2024 //
BUSINESSWIRE
SoftBank Group launches AI healthcare joint venture with Tempus AI
27 Jun 2024 //
REUTERS
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.